التفاصيل البيبلوغرافية
العنوان: |
Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience |
المؤلفون: |
William J. Hogan, Ahmed K. Abou Hussein, Mark R. Litzow, Naseema Gangat, Aref Al-Kali, Mrinal M. Patnaik, Michelle A. Elliott, Darci Zblewski, Shahrukh K. Hashmi |
المصدر: |
Leukemia & Lymphoma. 59:2737-2739 |
بيانات النشر: |
Informa UK Limited, 2018. |
سنة النشر: |
2018 |
مصطلحات موضوعية: |
0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Myeloid, Unclassifiable MDS, business.industry, Myelodysplastic/Myeloproliferative Neoplasm, Chronic myelomonocytic leukemia, Hematology, medicine.disease, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Internal medicine, Atypical chronic myeloid leukemia, Medicine, Single institution, business, Survival rate |
الوصف: |
Myelodysplastic/myeloproliferative overlap neoplasms (MDS/MPNs) are rare myeloid disorders that comprise chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia (aCML), juvenile m... |
تدمد: |
1029-2403 1042-8194 |
URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_________::bf24c012371398507aeae726cbc02dc6 https://doi.org/10.1080/10428194.2018.1436705 |
رقم الأكسشن: |
edsair.doi...........bf24c012371398507aeae726cbc02dc6 |
قاعدة البيانات: |
OpenAIRE |